Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pfanstiehl is a premier manufacturer of high-purity, low-endotoxin carbohydrates, amino acids, and pharmaceutical excipients for the biopharmaceutical industry. Operating as a specialized Contract Development and Manufacturing Organization (CDMO), the company focuses on the production of critical components used to stabilize biologics, vaccines, and cell culture media. Pfanstiehl's expertise includes the custom synthesis of complex carbohydrates and the handling of highly potent active pharmaceutical ingredients (HPAPIs) under strict cGMP conditions. Based in Waukegan, Illinois, the company has a century-long history of supporting drug development from clinical stages through commercial launch. Their products are essential for ensuring the safety, efficacy, and shelf-life of advanced therapeutic modalities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ferro Pfanstiehl Laboratories.